Massive Bio and PrecisCa Announce Strategic Partnership to Expand Cancer Patient Access to Clinical Trials Across the U.S. AOL.com
Roughly half the world's population is infected with the stomach bacterium Helicobacter pylori, which is responsible for about 90% of gastric cancers. However, until now, it has been unclear why some H. pylori infections lead to a rare form of lymphoma in the stomach while others don't.
Massive Bio and PrecisCa Announce Strategic Partnership to Expand Cancer Patient Access to Clinical Trials Across the U.S. Business Wire
An experimental compound called AP503 significantly strengthened bones in mice by activating GPR133, a receptor that boosts bone formation while slowing bone loss. Because the same treatment has also been linked to stronger muscles, researchers see intriguing potential for combating age-related decline and…
SOTIO Doses First Patient in Phase 1/2 CADENCIA-01 Clinical Trial of SOT109, a CDH17-Targeting ADC for Colorectal Cancer BioSpace
Tyra rolls toward pivotal cancer study even as stock deflates Fierce Biotech
«Это промежуточная победа»: Маргарита Симоньян откровенно рассказала о борьбе с онкологией Radio1.ru
Amgen's Imdelltra scores again in small cell lung cancer pharmaphorum
Исследование: Helicobacter pylori может быть связана с 22% случаев колоректального рака Vademec.ru
Исследование: Helicobacter pylori может быть связана с 22% случаев колоректального рака Vademec.ru
Semaglutide, the drug found in Ozempic and Wegovy, was linked to nearly 40% fewer asthma attacks in a large real-world study. It was also associated with about 20% fewer COPD flare-ups. Researchers say GLP-1 drugs may offer respiratory benefits in addition to their effects on diabetes and obesity, but clinical trials…
How advancements in blood cancer research are saving lives WXXI News
Употребление очень горячих напитков втрое повышает риск рака пищевода Наука Mail